Skip to content

BCBS Alabama

Does BCBS Alabama cover Wegovy for Weight Loss?

Yes. BCBS Alabama covers Wegovy for weight loss with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.

Policy document

  • Employer and ACA Marketplace: Covered with requirements. See the qualification pathways below.

Earliest policy review June 2, 2026. How we verify · Check your exact plan

Full requirements: Wegovy for Weight Loss (2 plan types)

Applies to Employer and ACA Marketplace plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

Adult obesity

All of:

  • Age ≥ 18 years
  • BMI ≥ 30 kg/m2 (or ≥ 23 kg/m2 for South Asian, Southeast Asian, East Asian adults)

Adult overweight with comorbidity

All of:

  • Age ≥ 18 years
  • BMI ≥ 27 kg/m2 (or ≥ 23 kg/m2 for South Asian, Southeast Asian, East Asian adults)

Plus any one of:

  • Hypertension
  • Type 2 diabetes
  • Dyslipidemia
  • OSA
  • CVD
  • MASH
  • other weight-related comorbidity

Pediatric obesity (age 12+)

All of:

  • Age ≥ 12 years
  • BMI ≥ 95th percentile for age/sex OR ≥ 30 kg/m2 (whichever is lower)

Documentation to bring

  • Baseline BMI documentation meeting threshold (≥ 30 kg/m2, or ≥ 27 kg/m2 with comorbidity, or ≥ 23 kg/m2 for qualifying Asian ethnicities)
  • Documentation of qualifying weight-related comorbidity if BMI 27–29.9 kg/m2
  • For pediatric patients: documentation of BMI ≥ 95th percentile for age/sex
  • Documentation of reduced calorie diet and increased physical activity as adjunct

Approval and renewal

  • Renewal: At least 5% weight loss after 12 weeks at a therapeutic dose is required for continuation. Policy states efficacy should be assessed after 12 weeks at therapeutic dose.
  • Renewal: At least 12 weeks on therapy before the first renewal.

Not covered when

  • Concomitant use with other semaglutide-containing products not recommended
  • Concomitant use with any other GLP-1 receptor agonist not recommended
  • Pregnancy

Policy note: Policy covers both Wegovy subcutaneous injection and Wegovy tablet (oral semaglutide) formulations. Wegovy HD (higher-dose subcutaneous) is listed separately in FDA table but shares the same weight loss indication. Pediatric coverage (age ≥ 12) is noted in FDA labeling for subcutaneous injection. The 5% weight loss threshold at 12 weeks is cited from guidelines as the efficacy assessment standard.

Policy effective April 20, 2026 · verified June 2, 2026 · source: Albp Weight Management Paql Prog Sum · View policy document (PDF)

Open on its own page →

Questions people ask
Does BCBS Alabama cover Wegovy?
Yes. BCBS Alabama covers Wegovy for weight loss with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.
What does BCBS Alabama require to renew Wegovy?
Weight Loss — Applies to Employer and ACA Marketplace plans. At least 5% weight loss after 12 weeks at a therapeutic dose is required for continuation. Policy states efficacy should be assessed after 12 weeks at therapeutic dose. At least 12 weeks on therapy before the first renewal.
How current is this information?
The oldest review date among the policies on this page is June 2, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

Also under BCBS Alabama: Mounjaro, Ozempic, Zepbound

Wegovy under other plans: Alabama Medicaid, BCBS Arizona, BCBS Arkansas, BCBS Louisiana, BCBS Massachusetts, BCBS Michigan, BCBS Minnesota, BCBS Nebraska

All insurance plans · All medications

Summary of BCBS Alabama's written policy, not a guarantee of coverage. Plans vary by employer and benefit design.